Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Krakow
Clinical trial register · Poland

Clinical Trials in Krakow, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 25 Wroclaw 15 Lodz 14 Krakow 14 Poznan 11
Narrow the registerReset
Recruitment status
Phase
Site location
Warsaw25 Wroclaw15 Lodz14 Krakow14 Poznan11
All 37 locations
Target enrolment
to

Trials with a site in Krakow

14 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Takeda
Observational
94
Krakow, Lodz, Warsaw, Zabrze
2026-09-24
Recruiting
Takeda
Observational
110
Poznan, Bydgoszcz, Krakow, Lublin, Warsaw, Opole, Przemyśl, Bialystok
2026-08-13
Recruiting
Takeda
Phase 3
300
Wroclaw, Krakow, Warsaw, Katowice, Skorzewo
2026-05-21
Recruiting
Takeda
Phase 3
1,182
Bialystok, Bytom, Krakow, Nowa Sól, Opole, Poznan, Sochaczew, Torun
2026-03-11
Recruiting
Takeda
Phase 3
347
Gmina Świecie, Krakow, Lodz, Wroclaw
2025-07-15
Recruiting
Takeda
Phase 3
59
Krakow, Lublin, Warsaw, Gdansk
2025-05-06
Active, closed
Takeda
Phase 3
601
Bydgoszcz, Krakow, Wroclaw, Gdynia, Częstochowa, Elblag, Poznan, Warsaw
2025-03-10
Recruiting
Takeda
Phase 3
1,088
Poznan, Krakow, Katowice, Sochaczew, Warsaw, Opole, Bialystok, Bytom
2025-03-03
Active, closed
Takeda
Phase 3
2,099
Poznan, Krakow, Katowice, Kłodzko, Wroclaw, Lublin, Lódz, Nadarzyn
2024-09-04
Active, closed
Takeda
Observational
50
Wroclaw, Poznan, Bydgoszcz, Krakow, Lublin, Warsaw, Rzeszów, Bystra
2023-05-22
Recruiting
Takeda
Phase 3
240
Krakow, Wroclaw, Warsaw, Rzeszów, Gdansk, Katowice, Szczecin, Lodz
2023-05-16
Recruiting
Takeda
Observational
70
Wroclaw, Poznan, Krakow, Lublin, Tomaszow Mazowiecki, Warsaw, Gdansk, Katowice
2022-03-08
Recruiting
Takeda
Phase 3
120
Krakow, Wroclaw, Warsaw, Rzeszów, Gdansk, Katowice, Szczecin, Lodz
2022-02-10
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Takeda
Phase 3
245
Krakow, Wroclaw, Gdansk, Olsztyn
2018-10-04
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 30 October 2026. https://priyalifescience.com/clinical-trials-poland/city/krakow

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Krakow that also match the filters currently applied.

How many clinical trials are recruiting in Krakow?

10 of the 14 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Krakow), 14 studies
PhaseStudiesRecruitingShare
Phase 310771.4%
Observational4328.6%

Most active sponsors

Lead sponsors with the most studies (Krakow)
Lead sponsorStudiesRecruiting
Takeda1410
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.